Skip to main content
Publications
Goldberg X, Castano-Vinyals G, Espinosa A, Carreras A, Liutsko L, Sicuri E, Foraster M , O'Callaghan-Gordo C, Dadvand P, Moncunill G, Dobano C, Cortes B, Pleguezuelos V, Straif K, Garcia-Aymerich J, de Cid R, Cardis E, Kogevinas M. Mental health and COVID-19 in a general population cohort in Spain (COVIVAT Study) . Soc Psychiatry Psychiatr Epidemiol. 2022 Dec;57(12):2457-68. doi: 10.1007/s00127-022-02303-0
Cruz Rivera S, Aiyegbusi OL, Ives J, Draper H, Mercieca-Bebber R, Ells C, Hunn A, Scott JA, Fernandez CV, Dickens AP, Anderson N, Bhatnagar V, Bottomley A, Campbell L, Collett C, Collis P, Craig K, Davies H, Golub R, Gosden L, Gnanasakthy A , Haf Davies E, von Hildebrand M, Lord JM, Mahendraratnam N, Miyaji T, Morel T, Monteiro J, Zwisler AO, Peipert JD, Roydhouse J, Stover AM, Wilson R, Yap C, Calvert MJ. Ethical considerations for the inclusion of patient-reported outcomes in clinical research: the PRO ethics guidelines . JAMA. 2022 May 17;327(19):1910-9. doi: 10.1001/jama.2022.6421
Rodes-Cabau J, Horlick E, Ibrahim R, Cheema AN, Labinaz M, Nadeem N, Osten M, Cote M, Marsal JR , Rivest D, Marrero A, Houde C. Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: the CANOA randomized clinical trial . JAMA. 2015 Nov 24;314(20):2147-54. doi: 10.1001/jama.2015.13919
David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM , Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec 1;5(6):935-42.
Kroenke K, West SL, Swindle R, Gilsenan A , Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial . JAMA. 2001 Dec 19;286(23):2947-55.